Posters simples

Posters affichés le Mercredi 19 Avril

  • PS1-001 - A beneficial effect of dulaglutide - Corinne SIMON (Tours)
  • PS1-002 - A comparative study of QT prolongation with Serotonin Reuptake Inhibitors (SRIs) – François MONTASTRUC (Toulouse)
  • PS1-003 - Accidental ingestion of a minoxidil hair lotion in a child: a severe case report - Stéphane SAVOUROUX (Nantes)
  • PS1-004 - Addiction to kaolin consumption during pregnancy: what about metropolitan France ? - Pascal CAILLET (Nantes)
  • PS1-005 - Adherence to guidelines for initial treatment of hypertension : description, trends over time and determinants - Marine CAMPION (Rennes)
  • PS1-006 - Adverse Drug Reactions of idélalisib: study in the French Pharmacovigilance Database - Sylvine PINEL (Paris)
  • PS1-007 - Adverse effects related to brentuximab: a systematic retrospective study - Béatrice CLARIVET (Montpellier)
  • PS1-008 - Albuminemia in preoperative: Interest and limit - Hakim EL ALAMA (Casablanca - Maroc)
  • PS1-009 - An UPLC-MS/MS method for human plasma quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib). Application to treated melanoma patients - Marine ROUSSET (Bordeaux)
  • PS1-010 - Antibiotic’s real life profile and safety : a regional study - Marie-Blanche VALNET RABIER (Besançon)
  • PS1-011 - Antineoplastic, which impact of age and comorbidities? – Malak ABOU TAAM (Reims)
  • PS1-012 - Antiproliferative effect of Berberis hispanica alkaloids extract on Hep2 laryngeal cancer cells - Amina BOUDJLIDA (Alger - Algérie)
  • PS1-013 - Antipsychotic use in pregnancy in France: Is Reproductive Safety different according to the indication? - François MONTASTRUC (Toulouse)
  • PS1-014 - Anti-thrombotic effects of the polysaccharide from Cydonia oblonga Miller - Adili ABUDOUREHEMAN (Urumqi - Chine)
  • PS1-015 - Assessment of vancomycine trough concentration in severe infections - Mouna BEN SASSI (Tunis - Tunisie)
  • PS1-016 - Atypical response of spondyloarthritis to biological treatments: think about Whipple’s disease – Pierre GILLET (Vandœuvre Lès Nancy)
  • PS1-017 - Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation – Theodora ANGOULVANT (Tours)
  • PS1-018 - Bullous hemorrhagic dermatosis, unfractionated heparine, low-molecular-weight heparin, danaparoïde and fondaparinux: analysis of the French pharmacovigilance database - Marta UCEDA-MARTIN (Strasbourg)
  • PS1-019 - Coma following AB-FUBINACA and 3-MeO-PCP consumption: a case report - Hélène LOMENECH (Nantes)
  • PS1-020 - Comparative P-gp and BCRP efflux transport of direct oral anticoagulants - Sophie HODIN (Saint-Etienne)
  • PS1-021 - Consumption of opioid analgesics, 2006-2015 - Simon COUTURIER (Bordeaux)
  • PS1-022 - Continuous infusion of vancomycin in critically ill children: do we achieve the target? - Mathieu GÉNUINI (Paris)
  • PS1-023 - Coronary heart disease during tyrosine kinase inhibitors therapy used in haemato-oncology : Study in the French Pharmacovigilance Database - Sandrine COMBRET (Dijon)
  • PS1-024 - Creation of pharmacovigilance accountability study software - Hakim EL ALAMA (Casablanca - Maroc)
  • PS1-025 - Dabigatran-related nephropathy in a patient with a pre-existing vascular nephropathy - Marie-Noëlle OSMONT (Rennes)
  • PS1-026 - Development and validation of an HPLC method for the therapeutic drug monitoring of 11 beta-lactams antibiotics - Elise PAPE (Nancy)
  • PS1-027 - Development of a new HPLC method for determination of Capecetabine and its metabolite 5FU in plasma - Dorra BEN SAID (Tunis - Tunisie)
  • PS1-028 - Development of a non-parametric population model and a bayesian estimator for tacrolimus in renal Tunisian transplant patients - Mouna BEN SASSI (Tunis - Tunisie)
  • PS1-029 - Development of follicular B cell lymphoma after treatment with Sofosbuvir in chronic hepatitis C virus - Roya NILI (Paris)
  • PS1-030 - Direct Oral Anticoagulants appropriateness’ prescriptions in 2016: analysis from community pharmacies - Johana BÉNÉ (Lille)
  • PS1-031 - Direct Oral Anticoagulants appropriateness’ prescriptions in a French University Hospital Center in 2016. – Johana BENE (Lille)
  • PS1-032 - Disulone® and hyperferritinemia : a case report - Charlotte ORSINI (Rouen)
  • PS1-033 - Donepezil-induced hypersexuality: an unexpected adverse drug reaction - Louise TRIQUET (Rennes)
  • PS1-034 - Drug-induced blepharospasm: a review of 20 years’ experience in the French pharmacovigilance database – Alexandre QUILLET (Poitiers)
  • PS1-035 - Drug-induced bone loss: A study of the French and Spanish PharmacoVigilance DataBases – Haleh BAGHERI (Toulouse)
  • PS1-036 - Drugs incriminated in fixed drug eruption - Mouna BEN SASSI (Tunis - Tunisie)
  • PS1-037 - Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4 - Charleine ZUSSY (Montpellier)
  • PS1-038 - Effect of glucarpidase on methotrexate levels and renal function : about five cases - Aurélie MARTINEZ (Montpellier)
  • PS1-039 - Effect of Total Flavonoids of Cydonia oblonga Mill. on blood pressure, myocardial hypertrophy and mediators of inflammation in spontaneously hypertensive rats - Ainiwaer WUMAIER (Urumqi - Chine)
  • PS1-040 - Effect of total flavonoids of Cydonia oblonga Miller on the blood pressure and vascular endothelial function in spontaneously hypertensive rats – Wumaier AINIWAER (Urumqi - Chine)
  • PS1-041 - Efficacy of metformin monotherapy on glycemic control, weight and serum lipids in drug-naive patients with type 2 diabetes: systematic review and meta-analysis of randomized placebo-controlled trial – Jean-Luc FAILLIE (Montpellier)
  • PS1-042 - Encapsulated exenatide once weekly: is there a link between the occurrence of cutaneous nodules and a decrease in efficacy? - Perrine ROBIN (Montpellier)
  • PS1-043 - Energy drinks are not "so good"... - Caroline VIGIER (Nice)
  • PS1-044 - Evaluation of medication adherence in elderly patients hospitalized in the endocrinology/diabetology service of the Tunisian military hospital - Safa LOUHICHI (Tunis - Tunisie)
  • PS1-045 - Evaluation of placebo use by Haitian physicians in 2016 - Elysée Junior Nérisson JOSEPH (Port-Au-Prince - Haïti)
  • PS1-046 - Evaluation of the knowledge of the treatment of chronic disease in a cohort of elderly subjects - Lobna BEN MAHMOUD (Sfax - Tunisie)
  • PS1-047 - Evaluation of the nocebo effect: descriptive study in a French pharmacy – Marion LEPELLEY (Grenoble)
  • PS1-048 - Exceptional case of hepatotoxicity associated with methoxsalen - Fatma BEN SALEM (Tunis - Tunisie)
  • PS1-049 - First case of tubulointerstitial nephropathy associated with vedolizumab - Frédérique BEAU-SALINAS (Tours)
  • PS1-050 - Haematological side effects of drugs used in psychiatry – Anne DAUTRICHE (Dijon)
  • PS1-051 - High doses of biotin in chronic progressive multiple sclerosis, patient’s appreciation of an effective treatment? - Laurence GABRIEL (Troyes)
  • PS1-052 - IgE‐mediated anaphylaxis to PPIs–cross‐reacting study – Julien MAHE (Nantes)
  • PS1-053 - Impairment of calcium homeostasis by methylglyoxal in cardiomyocytes via calcium channels: a key role in the development of diabetic cardiomyopathy - Hélène PEYRET (Reims)
  • PS1-054 - Incidence of prescribing errors from ambulatory prescriptions in Bouaké - Mamadou KAMAGATÉ (Bouaké - Côte d'ivoire)
  • PS1-055 - Increased reporting of adverse drug reactions in a hospital emergency department – Emilie DEHOURS (Toulouse)
  • PS1-056 - Infections associated with ruxolitinib: study in the French Pharmacovigilance Database - Sylvine PINEL (Paris)
  • PS1-057 - Influence of diet on hepatic metabolism of drugs - Oussama HADEQ (Casablanca - Maroc)
  • PS1-058 - Injectable Potassium Chloride: Improve prescription to prevent accidents - Marwa KLAI (Lyon)
  • PS1-059 - Interaction between statins and fusidic acid: an analysis from literature and Vigibase® data – Hélène THEOPHILE (Bordeaux)
  • PS1-060 - Interest of nitrous oxide as an analgesic in dental care - Tony PRUD'HOMME (Nantes)
  • PS1-061 - Interferon β-1b-induced acute pancreatitis - Imen HAMZA (Tunis - Tunisie)
  • PS1-062 - Intracranial hemorrhage following oral anticoagulant treatment: a retrospective comparative study assessing short-term mortality - Marie-Delphine GUILLEMIN (Lyon)
  • PS1-063 - Is psychostimulant substances use in slam a pharmacological issue ? - Benoît SCHRECK (Nantes)
  • PS1-064 - Knowledge and recommendations of the population on street drugs - Mamadou KAMAGATÉ (Bouaké - Côte d'ivoire)
  • PS1-065 - Kratom (Mitragyna speciosa) "phyto-toxicomania" : About a case of acute hepatitis – Reynald LE BOISSELIER (Caen)

 

Posters affichés le Jeudi 20 Avril

  • PS2-001 - Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients - Aurélie DAUMAS (Marseille)
  • PS2-002 - Male infertility and drug exposure: a feasibility study using the new database HOMERE - Mélanie ARAUJO (Toulouse)
  • PS2-003 - Medication adherence to antihypertensive treatment using Morisky medication adherence scale - Fatma Zahra BEN JEMIA (Tunis - Tunisie)
  • PS2-004 - Medication management in the Elderly: a French cross-sectional study in Hautes-Pyrénées - Haleh BAGHERI (Toulouse)
  • PS2-005 - Mepolizumab versus omalizumab and prednisone : what about the safety ? - Malak ABOU TAAM (Reims)
  • PS2-006 - Methylnaltrexone (Relistor®) as a sentinel drug? Using hospital prescription to detect severe opiate-induced constipation cases and their characteristics - Farid KHELOUFI (Marseille)
  • PS2-007 - Milnacipran, modulation of pain and patients with fibromyalgia - Nicolas MACIAN (Clermont-Ferrand)
  • PS2-008 - Monoclonal antibodies side effects: a retrospective study of 43 patients - Fatma BEN SALEM (Tunis - Tunisie)
  • PS2-009 - Myocarditis Related to ioxitalamic acid: a case report - Lobna BEN MAHMOUD (Sfax - Tunisie)
  • PS2-010 - Neonatal necrotizing enterocolitis: what is the role of drugs? - Floriane TIXIER (Lyon)
  • PS2-011 - Non-linear elimination pharmacokinetics of tramadol following administration of extended-release tablets - Yoann CAZAUBON (Reims)
  • PS2-012 - Nonsteroidal anti-inflammatory drugs (NSAIDs) and necrotizing fasciitis: even when used by local route - Christelle PHILIBERT (Montpellier)
  • PS2-013 - Ocular toxicity after intracameral injection of cefuroxime during cataract surgery : a study about French cases and a literature review - Agnès ANDORRA (Clermont-Ferrand)
  • PS2-014 - Off label use of clonidine in children and adolescents: safety data from French Pharmacovigilance Database - Elodie MATUSIK (Lille)
  • PS2-015 - Off-label use of clonidine in children and adolescent for attention-deficit/hyperactivity disorder in France: a study among pediatric neurologists and child and adolescent psychiatrists using the French pharmacovigilance network - Marine AUFFRET (Lille)
  • PS2-016 - Olanzapine-induced stuttering: a case report and review of the literature - Frédérique BEAU-SALINAS (Tours)
  • PS2-017 - Oral dosage form administration practice in children under 6 years of age: A survey study of paediatric nurses – Audrey LAJOINIE (Lyon)
  • PS2-018 - Outpatient antibiotic prescriptions with high risk of bacterial resistance in France: A National Healthcare Insurance database analysis – Agnès SOMMET (Toulouse)
  • PS2-019 - Outpatient consumption of antibiotics at high bacterial resistance risk in 2014 in France - Agnès SOMMET (Toulouse)
  • PS2-020 - Overview of the use of a non-activated prothrombin complex concentrate as a reversal agent of direct oral anticoagulants in a hospital - Hao-Sian LY (Boulogne-Billancourt)
  • PS2-021 - Paroxetine-clarithromycin: a drug-drug interaction to highlight! - Seda BAKIRCI (Nice)
  • PS2-022 - Peripheral neuropathy associated with donepezil: a case report - Sabrina PIERRE (Lyon)
  • PS2-023 - Pharmacovigilance National Survey of tramadol-induced Adverse Drug Reactions in adults - Florence MOULIS (Toulouse)
  • PS2-024 - Population Pharmacokinetic of bupivacaine after Transversus Abdominis Plane Block after cesarean section - Hanene ELJEBARI (Tunis - Tunisie)
  • PS2-025 - Population pharmacokinetics of ciprofloxacin in adult patients - Olivier MANGIN (Paris)
  • PS2-026 - Posterior-Reversible Encephalopathy Syndrome (PRES) after dobutamine and atropine stress echocardiography: first case report - Camille FLECK (Dijon)
  • PS2-027 - Predictors of methotrexate-induced toxicity and treatment outcome in patients with acute lymphoblastic leukemia treated with EORTC 58951 protocol - Lobna BEN MAHMOUD (Sfax - Tunisie)
  • PS2-028 - Pregnancy outcome in women exposed to thiocolchicoside during pregnancy: analysis of the Terappel DataBase - Aude LAMBERT (Strasbourg)
  • PS2-029 - Prescription of antidepressant drugs during pregnancy in France: a drug utilization study in EFEMERIS database - Caroline HURAULT-DELARUE (Toulouse)
  • PS2-030 - Prevalence of analgesic use in France, 2006-2014 - Amélie DAVELUY (Bordeaux)
  • PS2-031 - Proactive Pharmacovigilance: description and analysis of nivolumab's safety informations identified through the clinical data warehouse (CDW) of Brest University Hospital - Hélène JANTZEM (Brest)
  • PS2-032 - Proton pump inhibitors (PPI) and vitamin K antagonists (VKA) resistance: about an unknown interaction? - Louise GABORIAU (Lille)
  • PS2-033 - Psychiatric adverse events during aripiprazole associated to other antipsychotics : A retrospective study of cases reported within the French PharmacoVigilance database - Farid KHELOUFI (Marseille)
  • PS2-034 - Rabies vaccine-induced adverse drug reactions (ADRs): review of the French pharmacovigilance database (FPVD) between 2010 and 2015 - Colombe CALAS (Saint-Etienne)
  • PS2-035 - Reconstitution error of Infanrix Hexa® vaccine: highlight of the packing modalities - Anne Lise RUELLAN (Nantes)
  • PS2-036 - Redaction of a clinical trial protocol: a pragmatic check-list of safety aspects to consider - Stéphanie DURET (Bordeaux)
  • PS2-037 - Reversible cerebral vasoconstriction syndrome: illicit drugs may be involved - Marie GÉRARDIN (Nantes)
  • PS2-038 - Risk of “targeted therapies” in the elderly: the example of protein kinase inhibitors – Pascale OLIVIER (Toulouse)
  • PS2-039 - Safety profile of 5-fluorouracil: data from the French pharmacovigilance database over a 10 year period - Manon LAUNAY (Paris)
  • PS2-040 - Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with hematological malignancies - Christelle BOGLIONE-KERRIEN (Rennes)
  • PS2-041 - Searching hospital database for detecting the serious consequences related to use of drugs with an abuse potential – Emilie JOUANJUS (Toulouse)
  • PS2-042 - Security data about "free-access" self-medication - Malak ABOU TAAM (Reims)
  • PS2-043 - Severe cardiomyopathy during anti-PD1 treatment: From French pharmacovigilance network to animal models - Frank ROUBY (Marseille)
  • PS2-044 - Severe rhabdomyolysis in a patient treated with lumacaftor/ivacaftor association and aciclovir - Caroline JOYAU (Nantes)
  • PS2-045 - Stent thrombosis : Report of 11 cases - Fatma Zahra BEN JEMIA (Tunis - Tunisie)
  • PS2-046 - Sub-chronic toxicity of aqueous extract of Nigella sativa on Mus musculus and its antidiabetic and antioxydant effects on Rattus norvegicus - Karima BENSIAMEUR-TOUATI (Alger - Algérie)
  • PS2-047 - Synthetic lysergoids : a growing family of new psychoactive substances (NPS) - Reynald LE BOISSELIER (Caen)
  • PS2-048 - Tacrolimus drug monitoring during conversion from very high dose Prograf® to Advagraf® in a kidney transplant recipient - Emmanuelle MANOS (Marseille)
  • PS2-049 - Target blood level of continuous infusion cyclosporine in allogeneic hematopoietic stem cell transplantation - Haifa BEN ROMDHANE (Tunis - Tunisie)
  • PS2-050 - Targets for cardiovascular prevention: good use or misuse of drugs? - François GUEYFFIER (Lyon)
  • PS2-051 - Text message reminders for adolescents and young adults with poorly controlled type 1 diabetes - Nour IBRAHIM (Paris)
  • PS2-052 - The psychopharmacological profile of the Nigella seed oil in rats - Youness KADIL (Casablanca - Maroc)
  • PS2-054 - Therapeutic Drug monitoring of Vancomycin in Pediatric Patients - Dorra BEN SAID (Tunis - Tunisie)
  • PS2-055 - Thrombocytopenia associated with proton pump inhibitors: a study from the French pharmacovigilance database - Sibylle DE GERMAY (Bordeaux)
  • PS2-056 - TNFalpha blockers, depression and suicidality - Nadine PETITPAIN (Nancy)
  • PS2-057 - Tocilizumab (TCZ) and acne: an unexpected and potentially paradoxical side effect - Julie LEBRUN (Montpellier)
  • PS2-058 - Total Flavonoids from Cydonia oblonga Mill. protect human umbilical vein endothelial cells from hydrogen peroxide induced injury and apoptosis - Ainiwaer WUMAIER (Urumqi - Chine)
  • PS2-059 - Two dechlorinated chlordecone derivatives formed by in situ chemical reduction have lower genotoxicity, cytotoxicity and proangiogenic properties compared to the parent compound - Samuel LEGEAY (Angers)
  • PS2-060 - Urticaria associated to contraceptive intravaginal ring : first case report and litterature review - Marie-Sara AGIER (Tours)
  • PS2-061 - Use of placebos in clinical practice: a survey in the elderly population in Franche-Comté Region - Marie-Blanche VALNET RABIER (Besançon)
  • PS2-062 - Use of psychoactive substances by pharmacy students – Amélie DAVELUY (Bordeaux)
  • PS2-063 - Validation of an in vitro hypoxia-reoxygenation model of endothelial cells: study of anti-apoptotic effects of P2 and adenosine receptors - Catherine FELIU (Reims)
  • PS2-065 - Visual trouble associated with ciprofloxacin - Fatma BEN SALEM (Tunis - Tunisie)

Copyright © key4events - All rights reserved